日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA-SWITCH): a randomized, double-blind, double-dummy, active-controlled 26-week trial

在 2 型糖尿病患者中,从西格列汀转换为利拉鲁肽的疗效和安全性(LIRA-SWITCH):一项随机、双盲、双模拟、阳性对照的 26 周试验

Bailey, T S; Takács, R; Tinahones, F J; Rao, P V; Tsoukas, G M; Thomsen, A B; Kaltoft, M S; Maislos, M

Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe

肥胖:通往疾病的门户——欧洲肥胖症组织(EASO)关于欧洲日益严峻的公共卫生、临床和科学挑战的立场声明

Frühbeck, Gema; Toplak, Hermann; Woodward, Euan; Yumuk, Volkan; Maislos, Max; Oppert, Jean-Michel

Criteria for EASO-collaborating centres for obesity management

EASO合作肥胖管理中心的标准

Tsigos, Constantine; Hainer, Vojtech; Basdevant, Arnaud; Finer, Nick; Mathus-Vliegen, Elisabeth; Micic, Dragan; Maislos, Maximo; Roman, Gabriela; Schutz, Yves; Toplak, Hermann; Yumuk, Volkan; Zahorska-Markiewicz, Barbara

Management of obesity in adults: European clinical practice guidelines

成人肥胖症管理:欧洲临床实践指南

Tsigos, Constantine; Hainer, Vojtech; Basdevant, Arnaud; Finer, Nick; Fried, Martin; Mathus-Vliegen, Elisabeth; Micic, Dragan; Maislos, Maximo; Roman, Gabriela; Schutz, Yves; Toplak, Hermann; Zahorska-Markiewicz, Barbara

Serum prolactin in coeliac disease: a marker for disease activity

乳糜泻患者血清催乳素水平:疾病活动性的标志物

Reifen, R; Buskila, D; Maislos, M; Press, J; Lerner, A

The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulin

1型糖尿病患者体内循环胰岛素的来源是治疗性胰岛素。

Maislos, M; Mead, P M; Gaynor, D H; Robbins, D C